Gilman Sydney A. 4
4 · DiaMedica Therapeutics Inc. · Filed Nov 5, 2019
Insider Transaction Report
Form 4
Gilman Sydney A.
VP, Regulatory Affairs
Transactions
- Award
Stock Option (right to buy)
2019-11-01+50,000→ 50,000 totalExercise: $4.00Exp: 2029-10-31→ Common Stock (50,000 underlying)
Holdings
- 0
Common Stock
Footnotes (1)
- [F1]Vests in twelve nearly equal quarterly installments over three years.